Top

--Technology Readiness Evaluation (TRE) 07-1 Advanced Biological Agent Identification Technologies for the Joint Biological Point Detection System (JBPDS) Identifier Upgrade Effort

Active

USA-SNOTE-070807-005Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

This contract pertains to the Technology Readiness Evaluation (TRE) 07-1, focused on advanced biological agent identification technologies aimed at upgrading the Joint Biological Point Detection System (JBPDS) identifier. Following the initial Phase I completion in May 2007, selected organizations were invited to participate in Phases II and III, which involve laboratory evaluations of candidate technologies at Dugway Proving Ground, Utah, starting around October 1, 2007. Phase II is designed to assess the performance of these technologies compared to the current system's identifier, while Phase III will test their ability to automatically identify inactivated antigens in formulated tap water. Participation in these phases is limited to those previously selected, as no new participants are being solicited. The effort intends to provide the U.S. Army with data to determine if any of the proposed technologies offer superior performance for potential future upgrades to the JBPDS. This initiative is separate from other JBPDS program contract actions, emphasizing that the Army is under no obligation to select any participant's technology. The TRE serves as the exclusive government venue for evaluating identifier upgrade technologies at this time. The evaluations are slated to last up to four weeks, and all inquiries related to the TRE are directed to the Army's Technology Readiness Evaluation Team. The contract is managed under Department of Defense auspices and is based out of Aberdeen Proving Ground, Maryland.

General Info

Contract for evaluating advanced biological agent ID technologies to upgrade JBPDS at Dugway, 2007.

Agency

Department Of Defense → W6QK Acc-Apg

NAICS

334511 - Search, Detection, Navigation, Guidance, Aeronautical, and Nautical System and Instrument Manufacturing

Place of Performance

Set-Aside

NONE

Documents

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PostedAug 7

special-notice

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

AgencyDepartment Of Defense → W6QK Acc-Apg

ContactsNo contacts available

OfficeABERDEEN PROVING GROU, MD, 21010-5424, USA

Organization / AgencyDepartment Of Defense → W6QK Acc-Apg

Office AddressABERDEEN PROVING GROU, MD, 21010-5424, USA

ContactsNo contact information available

Full Description

Refer to the original Federal Business Opportunities announcement for this effort, which was published on March 20, 2007. Phase I of the TRE was completed in May 2007 and organizations which were invited to participate in Phases II & III of the TRE w ere notified by letter. This announcement is issued to provide additional information concerning the remaining Phases of the TRE. This announcement is not seeking additional participants for the upcoming phases, and any responses received as a result of th is notice will not be considered. As communicated in the March 20, 2007 announcement, Phase II evaluates identifier technologies for use with the Joint Biological Point Detection System (JBPDS). The tests are designed to provide data for the assessment of identifier technologies which may offer performance superior to that of the current system identifier. The U.S. Army is under no obligation to select any of the participating technologies. TRE 07-1 is a separate and distinct effort which has no connection to any of the JBPDS programs ongoing contract actions. Phases II & III will conduct laboratory evaluations of the proposed technologies, and are scheduled to occur at Dugway Proving Ground (DPG), UT beginning on or about 1 October 2007, for up to four wee ks in duration. All contractors selected in Phase I are encouraged to participate in the subsequent phases. Phase III will evaluate the technologies capability for automated identification of inactivated antigens in Formulated Tap Water. This testing will be scored separately from the Phase II portion of the TRE and will commence after Phase II testing has completed. Phase II participants should also be aware that at the current time the Government has no other venue, other than the TRE, through which upgr ade identifier technology will be evaluated for future block upgrade to the JBPDS. All questions concerning the TRE should be submitted to the US Army Technology Readiness Evaluation Team, contact@example.gov. Format is plain text.